Apolipoprotein C-III [apolipoprotein C-III]
- Terms
-
apo C-III
apo C-III-2
apoC-III
apolipoprotein C-III-0
apolipoprotein C-III-1
apolipoprotein CIII
sialyl apo C-III
-
Apo C-III
Apo C-III-2
ApoC-III
Apolipoprotein C-III-0
Apolipoprotein C-III-1
Apolipoprotein CIII
Sialyl Apo C-III
Sialyl Apolipoprotein C-III
A 9-kDa protein component of VERY-LOW-DENSITY LIPOPROTEINS and CHYLOMICRON REMNANTS. Apo C-III, synthesized in the liver, is an inhibitor of LIPOPROTEIN LIPASE. Apo C-III modulates the binding of chylomicron remnants and VLDL to receptors (RECEPTORS, LDL) thus decreases the uptake of triglyceride-rich particles by the liver cells and subsequent degradation. The normal Apo C-III is glycosylated. There are several polymorphic forms with varying amounts of SIALIC ACID (Apo C-III-0, Apo C-III-1, and Apo C-III-2).
- DUI
- D053305 MeSH Browser
- CUI
- M0073736
- Previous indexing
- Apolipoproteins C (1977-2006)
- History note
- 2007; use APOLIPOPROTEIN C-III (NM) 1979-2006
- Public note
- 2007; APOLIPOPROTEIN C-III was indexed under APOLIPOPROTEINS C 1985-2006 & under APOLIPOPROTEINS 1979-1984
Allowable subheadings
- AD
- administration & dosage
- AE
- adverse effects
- AG
- agonists
- AN
- analysis 1
- AI
- antagonists & inhibitors 4
- BI
- biosynthesis
- BL
- blood 3
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry 1
- CL
- classification
- DF
- deficiency
- DE
- drug effects
- EC
- economics
- GE
- genetics 3
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism 3
- PK
- pharmacokinetics
- PD
- pharmacology 2
- PH
- physiology
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use 1
- TO
- toxicity
- UL
- ultrastructure
- UR
- urine
APOC3 protein, human Chemical MeSH Browser